- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05927974
Investigating Dynamic Interactions in Distributed Cognitive Control Networks
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Routine intracranial monitoring (ICM) surgery involves placement of several (10-20) electrodes into the brain through a small opening to a target structure. Participants have been deemed a surgical candidate for this procedure, and detailed discussion of the procedure will occur as part of the surgical consent. The Investigators may place sensors (stickers) to monitor participant's arm/hand movements and brain activity. Sensors may be placed on participant's scalp and/or arms and legs. The Investigators may place a device on participant's wrist or finger to measure position (accelerometer). The Investigators may perform voice recordings, eye movement tracking, and motion capture recordings to obtain measures of how stimulation affects speech and other movements. These are performed without any attachment of devices.
Cognitive tasks: Multiple cognitive tasks may be used and will be decided upon based on the clinical symptoms, exam, or comorbidities. These may include Go/No-go, Simon/Stroop task, Stop-signal task, language tasks, Tower of London, gambling task, maze navigation, choice-reaction time, delay tasks, and attention tasks.
Cortico-cortical evoked potentials and Patterned Stimulation: Stimulus pulses at precise time intervals and or various patterns will be delivered across adjacent electrode contacts at a series of electrode sites while simultaneously recording neural activity at other electrodes. This does not require any activity from participant.
Tasks will be administered via computer monitor positioned in front of the you. This will be connected to a recording computer. Participant will respond via keyboard, mouse, or response button.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Jessica N Bentley, MD
- Phone Number: 2059347170
- Email: jbentley@uabmc.edu
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- Recruiting
- University of Alabama at Birmingham
-
Contact:
- Jessica N Bentley, MD
- Phone Number: 2059347170
- Email: jbentley@uabmc.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Eligible for surgery based on multi-disciplinary consensus review
- Have a diagnosis of medically-refractory epilepsy
- A minimum of 18 years of age
- Willingness to participate in the paradigms described in the protocol
Exclusion Criteria:
- Inability to provide full and informed consent
- Age younger than 18
- Are not physically able to participate in study-related activities
- Major medical or surgical complication
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
ICM Patients
Epillipsey Patients undergoing routine intracranial EEG monitoring for epilepsy.
|
Passive testing includes baseline recordings or behavioral tasks without stimulation.
Examples include language tasks, cognitive, and motor tasks.
Passive testing typically takes 30-60 minutes and does not require presence of an epileptologist as the tasks are of minimal or no risk.
Active testing includes any study activity in which stimulation occurs. The most frequent paradigm consists of delivering small amounts of electrical stimulation through the implanted grid/strip/depth electrodes. This will be either continuous stimulation or patterned stimulation such as intermittent theta-burst . Stimulation will range between 1-8 mAmp. The duration of these pulses will last between 2-5 seconds. Subjects may be asked to rest quietly or to perform behavioral tasks during stimulation. Since there is a risk of evoking seizure activity with active testing, presence of an epileptologist is required. Active testing will only occur once the PI/staff has communicated with the epileptologist regarding safety, feasibility, and timing of active testing. Active testing will typically take 60-90 minutes and is only performed once patients are back on their anti-seizure medications. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Go/No-go
Time Frame: Post-op through study completion, an average of 7 days.
|
Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities.
Tasks will be administered via computer monitor positioned in front of the subject.
This will be connected to a recording computer.
Participants will respond via keyboard, mouse, or response button.
|
Post-op through study completion, an average of 7 days.
|
|
Simon/Stroop task
Time Frame: Post-op through study completion, an average of 7 days.
|
Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities.
Tasks will be administered via computer monitor positioned in front of the subject.
This will be connected to a recording computer.
Participants will respond via keyboard, mouse, or response button.
|
Post-op through study completion, an average of 7 days.
|
|
Stop-signal task
Time Frame: Post-op through study completion, an average of 7 days.
|
Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities.
Tasks will be administered via computer monitor positioned in front of the subject.
This will be connected to a recording computer.
Participants will respond via keyboard, mouse, or response button.
|
Post-op through study completion, an average of 7 days.
|
|
Language task
Time Frame: Post-op through study completion, an average of 7 days.
|
Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities.
Tasks will be administered via computer monitor positioned in front of the subject.
This will be connected to a recording computer.
Participants will respond via keyboard, mouse, or response button.
|
Post-op through study completion, an average of 7 days.
|
|
Tower of London
Time Frame: Post-op Day Post-op through study completion, an average of 7 days.
|
Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities.
Tasks will be administered via computer monitor positioned in front of the subject.
This will be connected to a recording computer.
Participants will respond via keyboard, mouse, or response button.
|
Post-op Day Post-op through study completion, an average of 7 days.
|
|
Gambling task
Time Frame: Post-op through study completion, an average of 7 days.
|
Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities.
Tasks will be administered via computer monitor positioned in front of the subject.
This will be connected to a recording computer.
Participants will respond via keyboard, mouse, or response button.
|
Post-op through study completion, an average of 7 days.
|
|
Maze navigation
Time Frame: Post-op through study completion, an average of 7 days.
|
Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities.
Tasks will be administered via computer monitor positioned in front of the subject.
This will be connected to a recording computer.
Participants will respond via keyboard, mouse, or response button.
|
Post-op through study completion, an average of 7 days.
|
|
Choice-reaction time
Time Frame: Post-op through study completion, an average of 7 days.
|
Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities.
Tasks will be administered via computer monitor positioned in front of the subject.
This will be connected to a recording computer.
Participants will respond via keyboard, mouse, or response button.
|
Post-op through study completion, an average of 7 days.
|
|
Delay task
Time Frame: Post-op through study completion, an average of 7 days.
|
Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities.
Tasks will be administered via computer monitor positioned in front of the subject.
This will be connected to a recording computer.
Participants will respond via keyboard, mouse, or response button.
|
Post-op through study completion, an average of 7 days.
|
|
Attention task
Time Frame: Post-op through study completion, an average of 7 days.
|
Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities.
Tasks will be administered via computer monitor positioned in front of the subject.
This will be connected to a recording computer.
Participants will respond via keyboard, mouse, or response button.
|
Post-op through study completion, an average of 7 days.
|
|
Cortico-cortical evoked potentials
Time Frame: Post-op through study completion, an average of 7 days.
|
Stimulus pulses at precise time intervals will be delivered across adjacent electrode contacts at a series of electrode sites while simultaneously recording neural activity at other electrodes.
|
Post-op through study completion, an average of 7 days.
|
|
Patterned Stimulation
Time Frame: Post-op through study completion, an average of 7 days.
|
Stimulus pulses at various patterns will be delivered across adjacent electrode contacts at a series of electrode sites while simultaneously recording neural activity at other electrodes.
|
Post-op through study completion, an average of 7 days.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jessica N Bentley, MD, The University of Alabama at Birmingham
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300010350
- UAB (Other Identifier: UAB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on Passive testing
-
Southeast University, ChinaCompleted
-
Loma Linda UniversityWithdrawnDiabetic NeuropathiesUnited States
-
Meir Medical CenterUnknownOsteopenia of PrematurityIsrael
-
Norwegian Department of Health and Social AffairsSykehuset TelemarkCompletedCarcinoma | Adenoma | Colitis | Functional Colonic DiseaseNorway
-
University of Maryland, BaltimoreNational Institute on Disability, Independent Living, and Rehabilitation... and other collaboratorsRecruiting
-
Chiara MuléCompleted
-
Toronto Rehabilitation InstituteOntario Neurotrauma FoundationCompletedSpinal Cord Injury. | Osteoporosis.Canada
-
University Hospital, Basel, SwitzerlandUniversity of BaselRecruitingCleft Lip Palate | Congenital DisorderIndia
-
Indiana UniversityNational Heart, Lung, and Blood Institute (NHLBI)Terminated
-
Fortaleza UniversityCompletedHealthy Volunteers | StudentsBrazil